Researchers from the Perelman School of Medicine at the University of Pennsylvania have invented a new way to map specific DNA markings called 5-methylcytosine (5mC) which regulate gene expression and have key roles in health and disease.
In bid to extend cash runway, Cara to lay off workers, discontinue PhIII program in chronic kidney disease
Cara Therapeutics is cutting its workforce by nearly 50% and ending a Phase III program investigating an oral version of its opioid peptide in patients